Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

The Lancet Oncology

Volumn 18, Issue 11, 2017, Pages 1523-1531

  Tammemagi, Martin C ^a   Schmidt, Heidi ^b   Martel, Simon ^c   McWilliams, Annette ^d   Goffin, John R ^e   Johnston, Michael R ^f   Nicholas, Garth ^g   Tremblay, Alain ^h   Bhatia, Rick ⁱ   Liu, Geoffrey ^b   Soghrati, Kam ^b   Yasufuku, Kazuhiro ^b   Hwang, David M ^b   Laberge, Francis ^c   Gingras, Michel ^c   Pasian, Sergio ^c   Couture, Christian ^c   Mayo, John R ^j   Nasute Fauerbach, Paola V ^k   Atkar Khattra, Sukhinder ^l   Peacock, Stuart J ^l   Cressman, Sonya ^l   Ionescu, Diana ^l   English, John C ^j   Finley, Richard J ^j   Yee, John ^j   Puksa, Serge ^e   Stewart, Lori ^e   Tsai, Scott ^e   Haider, Ehsan ^m   Boylan, Colm ^m   Cutz, Jean Claude ^e   Manos, Daria ^f   Xu, Zhaolin ^f   Goss, Glenwood D ^g   Seely, Jean M ^g   Amjadi, Kayvan ^g   Sekhon, Harmanjatinder S ^g   Burrowes, Paul ^h   MacEachern, Paul ^h   Urbanski, Stefan ^h   Sin, Don D ⁿ   Tan, Wan C ⁿ   Leighl, Natasha B ^b   Shepherd, Frances A ^b   Evans, William K ^e   Tsao, Ming Sound ^b   Lam, Stephen ^j,l   more..

^a BROCK UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e JURAVINSKI CANCER CENTRE   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g OTTAWA REGIONAL CANCER CENTRE   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^j VANCOUVER GENERAL HOSPITAL   (Canada)

^k QUEEN S UNIVERSITY   (Canada)

^l BRITISH COLUMBIA CANCER AGENCY   (Canada)

^m MCMASTER UNIVERSITY   (Canada)

ⁿ ST PAUL S HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; BODY MASS; BRONCHOSCOPY; CANADA; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EDUCATION; FAMILY HISTORY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SHORT FORM 12; SMOKING; SMOKING CESSATION; SPIROMETRY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; VERY ELDERLY; AGE DISTRIBUTION; AREA UNDER THE CURVE; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; SEX RATIO; SURVIVAL ANALYSIS; TUMOR INVASION; X-RAY COMPUTED TOMOGRAPHY;

AGE DISTRIBUTION; AGED; AREA UNDER CURVE; CANADA; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ADJUSTMENT; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85031746153     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30597-1     Document Type: Article

References (32)

1. Aberle, DR, Adams, AM, Berg, CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
2. Humphrey, L, Deffebach, M, Pappas, M, et al. Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force recommendation. Evidence Synthesis No. 105. AHRQ Publication No. 13- 05188-EF-1, 2013, Agency for Healthcare Research and Quality, Rockville, MD.
3. Kovalchik, SA, Tammemagi, M, Berg, CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 369 (2013), 245–254.
4. Pinsky, PF, Berg, CD, Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?. J Med Screen 19 (2012), 154–156.
5. Tammemagi, CM, Pinsky, PF, Caporaso, NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 103 (2011), 1058–1068.
6. Tammemagi, MC, Katki, HA, Hocking, WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 368 (2013), 728–736.
7. Tammemagi, MC, Timothy, R, Church, TR, et al. Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med, 11, 2014, e1001764.
8. Li, K, Husing, A, Sookthai, D, et al. Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila) 8 (2015), 777–785.
9. Ten Haaf, K, Jeon, J, Tammemagi, MC, et al. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med, 14, 2017, e1002277.
10. Weber, M, Yap, S, Goldsbury, D, et al. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool. Int J Cancer 141 (2017), 242–253.
11. Tammemagi, MC, Freedman, MT, Pinsky, PF, et al. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 4 (2009), 710–721.
12. Tremblay, A, Taghizadeh, N, McWilliams, AM, et al. Low prevalence of high-grade lesions detected with autofluorescence bronchoscopy in the setting of lung cancer screening in the Pan-Canadian lung cancer screening study. Chest 150 (2016), 1015–1022.
13. McWilliams, A, Tammemagi, MC, Mayo, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369 (2013), 910–919.
14. Miller, MR, Hankinson, J, Brusasco, V, et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
15. WHO, International Agency for Research on Cancer. Pathology and genetics of tumours of the lung, pleura, thymus and heart, 2004, IARC Press, Lyon.
16. Travis, WD, Brambilla, E, Noguchi, M, et al. International Association For The Study Of Lung Cancer/American Thoracic Society/European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 (2011), 244–285.
17. Rami-Porta, R, Crowley, JJ, Goldstraw, P, The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15 (2009), 4–9.
18. Cressman, S, Peacock, SJ, Tammemagi, MC, et al. The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. J Thorac Oncol 12 (2017), 1210–1222.
19. Sin, D, Tammemagi, MC, Lam, S, et al. Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol 31 (2013), 4536–4543.
20. Gohagan, JK, Marcus, PM, Fagerstrom, RM, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest x-ray screening for lung cancer. Lung Cancer 47 (2005), 9–15.
21. Cuzick, J, A Wilcoxon-type test for trend. Stat Med 4 (1985), 87–90.
22. Brown, LD, Cai, TT, DasGupta, A, Interval estimation for a binomial proportion. Stat Sci 16 (2001), 101–133.
23. Fine, JP, Gray, RJ, A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
24. Rufibach, K, Use of Brier score to assess binary predictions. J Clin Epidemiol 63 (2010), 938–939.
25. Pepe, MS, Longton, G, Janes, H, Estimation and comparison of receiver operating characteristic curves. Stata J 9 (2009), 1–16.
26. Aberle, DR, DeMello, S, Berg, CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369 (2013), 920–931.
27. Field, JK, Duffy, SW, Baldwin, DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170.
28. Black, WC, Gareen, IF, Soneji, SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371 (2014), 1793–1802.
29. Patz, EF Jr, Greco, E, Gatsonis, C, Pinsky, P, Kramer, BS, Aberle, DR, Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 17 (2016), 590–599.
30. Yousaf-Khan, U, van der Aalst, C, de Jong, PA, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2·5-year screening interval. Thorax 72 (2017), 48–56.
31. Horeweg, N, Scholten, ET, de Jong, PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15 (2014), 1342–1350.
32. Patz, EF Jr, Pinsky, P, Gatsonis, C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174 (2014), 269–274.